3 Needs context
Approximately 40% of people do not see a measurable increase in VO2 max after engaging in 2.5 hours per week of guideline-based moderate-intensity exercise for several months.
"In fact, research has shown that approximately 40% of people do not see a measurable increase in their VO2 max even after engaging in guideline-based moderate-intensity exercise, which is about 2.5 hours of this type of exercise per week for several months." (said at 0:09:45)
Several exercise training trials evaluating standard or guideline-based exercise protocols have reported apparent non-response rates of roughly 20% to 40% when assessing changes in VO2 max. However, critical reviews of the literature show that categorizing individuals as 'non-responders' often conflates true physiological non-responsiveness with normal within-subject test-retest measurement error and lack of control comparator arms. Furthermore, physiological studies demonstrate that increasing training volume or intensity eliminates apparent VO2 max non-response, and individuals who do not show a VO2 max increase often still achieve measurable improvements in submaximal fitness, insulin sensitivity, and other cardiometabolic parameters.
Astrocytes in the brain are predominantly glycolytic and produce lactate that is taken up by neurons via MCT transporters for energy.
"In fact, neurons are used to using lactate because astrocytes in the brain, which are a supporting cell for neurons, they're mostly glycolytic. That means they're mostly using glucose as energy; they're not using mitochondria, and they're producing lactate as a byproduct. So astrocytes are churning out tons of lactate in the brain, and that lactate is being taken up by neurons through the MCT transporters and used as energy." (said at 0:36:53)
The speaker accurately describes the core tenets of the Astrocyte-Neuron Lactate Shuttle (ANLS) model: astrocytes possess a predominantly glycolytic metabolic profile compared to neurons, producing and exporting lactate via monocarboxylate transporters (MCTs, predominantly MCT1 and MCT4), which neurons take up (primarily via MCT2) to fuel oxidative metabolism. However, the claim that astrocytes 'are not using mitochondria' is an oversimplification. While astrocytes favor glycolysis to meet high-energy demands during processes like glutamate uptake, they possess functional mitochondria that actively engage in oxidative phosphorylation, the tricarboxylic acid cycle, and metabolic maintenance.
- supports: Bioenergetics and redox adaptations of astrocytes to neuronal activity. (Journal of neurochemistry 2016) · cited 254x in the literature
"To enable this, astrocytes are constitutively glycolytic, robustly expressing 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3)... Astrocyte-derived glycolytic lactate thus sustains the energy needs of neurons, which in contrast to astrocytes mainly rely on oxidative phosphorylation." (abstract, results)
pubmedfull study (doi) - supports: Astrocytes and neurons communicate via a monocarboxylic acid shuttle. (AIMS neuroscience 2020) · cited 42x in the literature
"The repertoire of MCTs in astrocytes and neurons allows them to communicate via monocarboxylic acids." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Universal Glia to Neurone Lactate Transfer in the Nervous System: Physiological Functions … (Biosensors 2020) · cited 35x in the literature
"In the last few decades, the concept of lactate shuttling between glial elements and neural elements has emerged in which the glial cells glycolytically metabolise glucose/glycogen to lactate, which is shuttled to the neural elements via the extracellular fluid." (abstract, results, passage verified)
pubmedfull study (doi)
Increased lactate utilization by neurons stimulates the release of norepinephrine in the brain.
"And when neurons in the brain are using more lactate, they're releasing a variety of neurotransmitters; they release more norepinephrine, for example, to help the brain working better, to have more focus and attention." (said at 0:40:27)
Preclinical animal research indicates that L-lactate can excite locus coeruleus neurons and trigger the release of norepinephrine in the brain, evoking physiological arousal. However, experimental findings demonstrate that this effect acts through a receptor-mediated signaling pathway independent of neuronal lactate uptake or metabolic utilization (caloric use). Furthermore, this mechanism has been demonstrated in rodent and in vitro models rather than direct human trials.
- context: Lactate-mediated glia-neuronal signalling in the mammalian brain. (Nature communications 2014) · cited 337x in the literature
"Here we present evidence that L-lactate, independently of its caloric value, serves as an astrocytic signalling molecule in the locus coeruleus (LC). The LC is the principal source of norepinephrine to the frontal brain and thus one of the most influential modulatory centers of the brain. Optogenetically activated astrocytes release L-lactate, which excites LC neurons and triggers release of norepinephrine. Exogenous L-lactate within the physiologically relevant concentration range mimics these effects. L-lactate effects are concentration-dependent, stereo-selective, independent of L-lactate uptake into neurons and involve a cAMP-mediated step." (abstract, results, passage verified)
pubmedfull study (doi)
35 Supported by research
During vigorous exercise, muscles synthesize lactate and myokines that enter circulation and signal to tissues to stimulate the synthesis of brain-derived neurotrophic factor (BDNF).
"During vigorous exercise, our muscles essentially become mini biochemical labs, synthesizing compounds like lactate and myokines. These aren't just muscle-bound; they get into circulation, travel to far-off tissues, and they signal to them, and they have a variety of benefits, including the synthesis of elements like brain-derived neurotrophic factor, or BDNF, crucial for brain health and neuronal health." (said at 0:00:15)
During vigorous exercise, contracting skeletal muscles produce metabolic byproducts and secretome proteins, specifically lactate and various myokines (such as irisin). These enter the systemic circulation, cross the blood-brain barrier or interact with peripheral and central targets, and stimulate the expression of brain-derived neurotrophic factor (BDNF) via pathways including SIRT1 and PGC-1α. Experimental studies in humans and animals, alongside mechanistic reviews, demonstrate that both exercise-induced lactate elevation and circulating exerkines promote central and circulating BDNF production, supporting neuroplasticity and brain health.
- supports: Physiological significance of elevated levels of lactate by exercise training in the brain… (Journal of bioscience and bioengineering 2023) · cited 62x in the literature
"Furthermore, improvement in brain function by lactate, particularly, through the expression of vascular endothelial growth factor and brain-derived neurotrophic factor, is being increasingly studied." (abstract, passage verified)
pubmedfull study (doi) - supports: Exerkines: A Crosstalk between Lactate Production, Exercise and Mental Health. (CNS & neurological disorders drug targets 2024) · cited 9x in the literature
"It is inferred that the BDNF expression mechanism can be induced by lactate, which in turn derives from the activation of SIRT pathways 1 and 2 and activates the PGC1-α cascade. The behavior of lactate concentration is intensity-dependent, directly related to the type of fast-twitch fibers (type IIb) and the recruitment of these fibers would potentiate the responses in the brain." (abstract, passage verified)
pubmedfull study (doi) - supports: Lactate infusion increases circulating pro-brain-derived neurotrophic factor levels in hum… (Frontiers in cellular neuroscience 2025) · cited 2x in the literature
"Plasma pro-BDNF levels increased 15 min post lactate infusion and stayed elevated throughout the recovery (55%-68%, p < 0.0286 vs. Saline)... In conclusion, these results suggest that lactate in isolation affects circulatory pro-BDNF, but not mBDNF levels. This implies that lactate may partly mediate the exercise response of pro-BDNF in humans." (abstract, results)
pubmedfull study (doi)
Improving cardiorespiratory fitness from below normal to low normal for age and sex is associated with a 2.1-year increase in life expectancy.
"So even going from a below normal VO2 max for your age group and gender to a low normal is associated with a 2.1-year increase in life expectancy." (said at 0:06:37)
A 46-year prospective cohort study of 5,107 middle-aged men (the Copenhagen Male Study, PMID 30139444) evaluated estimated VO2 max and long-term mortality. Compared with having cardiorespiratory fitness below the lower limit of normal (lowest 5%), having low normal fitness (next 45%) was associated with an increase in mean life expectancy of 2.1 years (95% CI: 0.7 to 3.4 years).
Increasing VO2 max from below normal to high normal is associated with a 2.9-year increase in life expectancy, and increasing to the upper limit of normal is associated with a 4.9-year increase in life expectancy.
"Bumping that up, going from a below normal to high normal VO2 max is associated with a 2.9-year increase in life expectancy, and going even further to the upper limit of normal is associated with 4.9 years, so almost a 5-year increase in life expectancy." (said at 0:06:48)
The statement directly reflects the findings of the Copenhagen Male Study (Clausen et al., 2018), which followed 5,107 middle-aged men over 46 years to assess cardiorespiratory fitness (estimated VO2 max via bicycle ergometer) and longevity. Compared to men with fitness below the lower limit of normal (lowest 5%), having high normal fitness (middle-to-upper 45%) was associated with a 2.9-year increase in mean life expectancy (95% CI: 1.5 to 4.2), while having fitness above the upper limit of normal (top 5%) was associated with a 4.9-year increase (95% CI: 3.1 to 6.7). Because these findings are based on an observational prospective cohort of men using survival modeling rather than an interventional trial directly testing fitness modification, the GRADE certainty is rated as low.
A 2018 JAMA study found that elite fitness performers (top 2.3%) had an 80% reduction in mortality risk compared to the lowest performers (bottom 25%).
"Another study published in JAMA in 2018 found that there was no apparent upper limit to the benefit of cardiorespiratory fitness on mortality, within normal ranges of human life expectancy of course. In fact, the study reported that elite performers—these are people that performed in the top 2.3% on the fitness test—had an 80% reduction in mortality risk compared to the lowest performers, so they performed in the bottom 25% on the fitness test." (said at 0:07:41)
A 2018 cohort study published in JAMA Network Open by Mandsager et al. analyzed 122,007 adult patients undergoing exercise treadmill testing. Participants were categorized into cardiorespiratory fitness performance groups: low (<25th percentile, bottom 25%) and elite (≥97.7th percentile, top 2.3%). The authors found no observed upper limit to the survival benefit of aerobic fitness. Compared to the low-performance group, elite performers had an 80% reduction in risk-adjusted all-cause mortality (adjusted hazard ratio [HR], 0.20; 95% CI, 0.16–0.24; P < .001).
In the 2018 JAMA study, elite fitness performers had a 20% mortality risk reduction compared to high performers (between top 25% and top 2.3%).
"And if you compare the elite performers to the high performers—so these folks did really well, but they were just under the elite, they were between the top 25% and the top 2.3%—the elite performers had a 20% mortality risk decline compared to even those high performers." (said at 0:08:12)
A 2018 cohort study published in JAMA Network Open by Mandsager et al. evaluated 122,007 patients undergoing exercise treadmill testing to assess the association between cardiorespiratory fitness and long-term all-cause mortality. Participants were categorized into fitness percentiles, where 'high' performers were in the 75th to 97.6th percentiles (the top 25% excluding the top 2.3%) and 'elite' performers were in the top 2.3% (≥97.7th percentile). Compared to high performers, elite performers had a statistically significant reduction in risk-adjusted all-cause mortality (adjusted hazard ratio, 0.77; 95% CI, 0.63–0.95), corresponding to an approximate 23% (roughly 20%) reduction in mortality risk.
- supports: Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing … (JAMA network open 2018) · cited 499x in the literature
"Consecutive adult patients referred for symptom-limited exercise treadmill testing were stratified by age- and sex-matched cardiorespiratory fitness into performance groups: low (<25th percentile), below average (25th-49th percentile), above average (50th-74th percentile), high (75th-97.6th percentile), and elite (≥97.7th percentile)... Risk-adjusted all-cause mortality was inversely proportional to cardiorespiratory fitness and was lowest in elite performers (elite vs low: adjusted hazard ratio [HR], 0.20; 95% CI, 0.16-0.24; P < .001; elite vs high: adjusted HR, 0.77; 95% CI, 0.63-0.95; P = .02)." (abstract, methods and results, passage verified)
pubmedfull study (doi)
In the 2018 JAMA study, individuals in the low-fitness group had a fivefold higher risk of death compared to elite performers.
"people in the low-fitness group had a fivefold higher risk of death than the elite performers." (said at 0:08:40)
In a 2018 cohort study of 122,007 adults undergoing exercise treadmill testing published in JAMA Network Open, researchers evaluated the relationship between cardiorespiratory fitness and all-cause mortality over a median follow-up of 8.4 years. Individuals in the lowest fitness group (<25th percentile) had an adjusted hazard ratio of 5.04 (95% CI, 4.10–6.20; P < .001) for all-cause mortality compared to elite performers (≥97.7th percentile), reflecting an approximately fivefold increase in the risk of death.
The risk of dying associated with low fitness is comparable to or larger than the risks associated with heart disease, smoking, or diabetes.
"But what is also so interesting is that the risk of dying due to low fitness was similar or even bigger than risks associated with having heart disease, smoking, or diabetes." (said at 0:08:45)
A large retrospective cohort study of 122,007 adults undergoing exercise treadmill testing with median 8.4 years of follow-up (Mandsager et al., 2018) directly compared the mortality risk of low cardiorespiratory fitness against traditional cardiovascular risk factors. The adjusted hazard ratios for all-cause mortality from coronary artery disease (HR 1.29, 95% CI 1.24-1.35), smoking (HR 1.41, 95% CI 1.36-1.46), and diabetes (HR 1.40, 95% CI 1.34-1.46) were comparable to the difference between below-average and above-average fitness (HR 1.41, 95% CI 1.34-1.49) and substantially lower than the risk associated with low versus elite fitness (HR 5.04, 95% CI 4.10-6.20).
- supports: Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing … (JAMA network open 2018) · cited 499x in the literature
"The increase in all-cause mortality associated with reduced cardiorespiratory fitness (low vs elite: adjusted HR, 5.04; 95% CI, 4.10-6.20; P < .001; below average vs above average: adjusted HR, 1.41; 95% CI, 1.34-1.49; P < .001) was comparable to or greater than traditional clinical risk factors (coronary artery disease: adjusted HR, 1.29; 95% CI, 1.24-1.35; P < .001; smoking: adjusted HR, 1.41; 95% CI, 1.36-1.46; P < .001; diabetes: adjusted HR, 1.40; 95% CI, 1.34-1.46; P < .001)." (abstract, results, passage verified)
pubmedfull study (doi)
Non-responders who fail to improve VO2 max with moderate-intensity exercise do experience VO2 max improvements when they incorporate vigorous-intensity exercise or HIIT.
"But when these what are called non-responders incorporated more vigorous-intensity exercise, such as high-intensity interval training, they do start to see improvements in VO2 max. So this suggests that adding higher-intensity exercise to an exercise routine can help eliminate that non-response and also can lead to greater benefits in cardiorespiratory fitness." (said at 0:10:17)
Randomized and crossover experimental trials in exercise physiology show that individuals classified as 'non-responders' to standardized moderate-intensity continuous exercise protocols typically demonstrate significant improvements in cardiorespiratory fitness (VO2 max or peak work output) when the exercise dose is augmented via increased intensity, volume, or high-intensity interval training (HIIT). Montero and Lundby (2017) directly demonstrated that non-response in cardiorespiratory fitness is dose-dependent and abolished upon increasing exercise stimulus.
A study by Benjamin Levine's group showed that two years of vigorous exercise intervention in 50-year-olds reversed cardiac stiffness and aging changes by up to 20 years, making heart structure resemble that of a 30-year-old.
"So there was a landmark study published from Ben Levine's group, and it was an intervention study and it showed that two years of vigorous exercise in 50-year-olds was able to reverse the aging of their hearts by as much as 20 years, effectively making their hearts look more like a 30-year-old, which in my opinion is simply astonishing: You're taking a 50-year-old heart and making it look like a 30-year-old heart." (said at 0:20:30)
In a prospective randomized controlled trial led by Benjamin Levine's group (Howden et al., Circulation 2018), 61 healthy sedentary middle-aged adults (mean age 53 ± 5 years) underwent either a 2-year progressive, high-intensity aerobic exercise training program or an attention control regimen. The 2-year exercise intervention significantly reduced left ventricular (LV) myocardial stiffness (decreasing the LV stiffness constant from 0.072 to 0.051) and increased maximal oxygen uptake by 18%, effectively reversing sedentary cardiac aging and restoring ventricular compliance toward levels characteristic of younger individuals.
- supports: Reversing the Cardiac Effects of Sedentary Aging in Middle Age-A Randomized Controlled Tri… (Circulation 2018) · cited 217x in the literature
"In a prospective, parallel group, randomized controlled trial, we examined the effect of 2 years of supervised high-intensity exercise training on LV stiffness. Sixty-one (48% male) healthy, sedentary, middle-aged participants (53±5 years) were randomly assigned to either 2 years of exercise training (n=34) or attention control (control; n=27)... In previously sedentary healthy middle-aged adults, 2 years of exercise training improved maximal oxygen uptake and decreased cardiac stiffness." (abstract, methods and conclusions, passage verified)
pubmedfull study (doi)
In the two-year Levine cardiac aging study, participants exercised 5 to 6 hours per week by the end of six months, including Zone 3 maximal steady state training and once-weekly Norwegian 4x4 HIIT intervals.
"By the end of the first six months, participants were exercising about 5 to 6 hours a week with a large portion of training being in that maximal steady state intensity exercise, which I referred to earlier in the podcast, it's often sometimes called Zone 3. It is a type of vigorous-intensity exercise. They also were incorporating more higher-intensity exercise, so they also did the Norwegian 4x4 VO2 training, VO2 max training protocol I just referred to, and they did that once a week." (said at 0:21:05)
The claim accurately describes the exercise protocol utilized in the randomized controlled trial conducted by Levine and colleagues (Howden et al., 2018). In this study, sedentary middle-aged participants underwent a two-year exercise intervention that ramped up over the first six months to a high-volume prescription, which included once-weekly 4x4 high-intensity interval training (HIIT) sessions, maximal steady-state exercise sessions, and moderate-intensity endurance training. The published trial demonstrated that two years of this exercise training significantly increased maximal oxygen uptake (VO2 max by 18%) and reduced left ventricular stiffness.
Lactate accumulation during high-intensity exercise acts as a signaling molecule to stimulate the expression and activity of GLUT4 glucose transporters on muscle cell membranes.
"So vigorous-intensity exercise, high-intensity interval training, when that lactate production accumulates, it stimulates the expression and activity of glucose Transporters on the muscle known as GLUT4, and this is on the muscle cell membrane, and so that lactate acts as a signaling molecule to increase the transport of glucose transporters on the muscle cells." (said at 0:24:55)
Preclinical and mechanistic evidence supports the claim that lactate generated during exercise acts as a signaling molecule to promote GLUT4 glucose transporter translocation and activity on skeletal muscle membranes. Mechanistic work demonstrates that lactate activates its receptor GPR81 in skeletal muscle, recruiting FARP1 and activating RAC1 to stimulate insulin-independent GLUT4 translocation and enhance glucose uptake. Because these signaling pathways have primarily been characterized in cellular and animal models along with post-exercise molecular expression analyses, the certainty of the evidence is low.
Lactate produced during vigorous exercise acts as a signaling molecule that activates PGC-1alpha, a primary regulator of mitochondrial biogenesis.
"When you're producing greater amounts of lactate, that actually activates one of the major pathways that regulates mitochondrial biogenesis; it's called PGC-1alpha. And again, lactate's acting as a signal to produce more of that PGC-1alpha." (said at 0:28:40)
Published physiological literature confirms that lactate, beyond serving as an oxidative fuel substrate, acts as a signaling molecule (sometimes termed a 'lactormone') during exercise. Exercise-induced lactate elevations stimulate signaling pathways (including AMPK and p38 MAPK cascades) that activate and upregulate peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), a master regulator of skeletal muscle mitochondrial biogenesis and oxidative metabolic adaptations.
Skeletal muscle acts as a sink to absorb and clear circulating compounds harmful to the brain, thereby protecting mental health and reducing the risk of neurodegenerative diseases.
"Not only are muscles little chemical-producing factories, but they also act like sponges to soak up compounds that can be harmful to the brain, improving mental health and reducing neurodegenerative disease risk." (said at 0:00:30)
Published research confirms that skeletal muscle can act as a metabolic sink for neurotoxic compounds, protecting the central nervous system and supporting mental health. In particular, exercise training upregulates kynurenine aminotransferases (KATs) in skeletal muscle via PGC-1α1. This enzymatic machinery clears circulating kynurenine—a metabolite linked to stress, depression, and neurotoxicity that readily crosses the blood-brain barrier—by converting it into kynurenic acid, which cannot cross the blood-brain barrier. Human and animal studies show this peripheral clearance mechanism directly reduces brain exposure to harmful metabolites and mediates resilience against depressive behaviors.
- supports: Skeletal muscle PGC-1α1 modulates kynurenine metabolism and mediates resilience to stress-… (Cell 2014) · cited 746x in the literature
"Activation of the PGC-1α1-PPARα/δ pathway increases skeletal muscle expression of kynurenine aminotransferases, thus enhancing the conversion of kynurenine into kynurenic acid, a metabolite unable to cross the blood-brain barrier. Reducing plasma kynurenine protects the brain from stress-induced changes associated with depression and renders skeletal muscle-specific PGC-1α1 transgenic mice resistant to depression induced by chronic mild stress or direct kynurenine administration." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Endurance exercise increases skeletal muscle kynurenine aminotransferases and plasma kynur… (American journal of physiology. Cell physiology 2016) · cited 172x in the literature
"KAT gene and protein expression was increased in the muscles of endurance-trained subjects compared with untrained subjects. Endurance exercise caused an increase in plasma KYNA within the first hour after exercise." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Kynurenines: Tryptophan's metabolites in exercise, inflammation, and mental health. (Science (New York, N.Y.) 2017) · cited 1381x in the literature
"Conversely, kynurenine accumulation can be suppressed by activating kynurenine clearance in exercised skeletal muscle. The effect of exercise training on depression through modulation of the kynurenine pathway highlights an important mechanism of interorgan cross-talk mediated by these metabolites." (abstract, passage verified)
pubmedfull study (doi)
In the Cooper 12-minute run test, VO2 max is estimated using the formula: (distance covered in meters minus 504.9) divided by 44.73.
"So the distance covered within that 12-minute period serves as the primary metric for evaluating VO2 max, which is then estimated using a formula. So it's distance in meters minus 504.9 and then divided by 44.73." (said at 0:30:27)
The statement accurately reflects the standard metric formula derived from Kenneth H. Cooper's 12-minute run test for estimating maximal oxygen uptake (VO2 max in mL/kg/min). The linear equation converts the distance covered in meters over 12 minutes using the formula: (distance in meters - 504.9) / 44.73.
Both high-intensity interval training and Zone 2 moderate-intensity training increase mitochondrial biogenesis in skeletal muscle, with HIIT stimulating it more rapidly.
"Again, both high-intensity interval training, Zone 2 training, also moderate-intensity training can increase mitochondrial biogenesis in skeletal muscle. HIIT does it more rapidly; it's a more potent stimulus, again, with lactate being a signaling molecule." (said at 0:30:14)
Both high-intensity interval training (HIIT/SIT) and moderate-intensity continuous training (MICT/Zone 2) stimulate mitochondrial biogenesis in skeletal muscle. Human muscle biopsy studies show that high-intensity interval exercise triggers rapid early molecular events involved in mitochondrial biogenesis—such as increased nuclear PGC-1α protein content and p53 phosphorylation immediately post-exercise—more potently per unit of time than continuous moderate exercise. This acute response is driven by metabolic perturbations, where exercise intensity and intracellular lactate accumulation act as key signaling stimuli.
Both moderate-intensity and vigorous-intensity exercise increase carnitine palmitoyltransferase (CPT) enzyme capacity in muscle.
"Both types of exercise training, moderate and also vigorous-intensity exercise, do increase the CPT enzyme capacity as well." (said at 0:31:48)
Published exercise physiology literature supports the statement that both moderate-intensity continuous exercise training and vigorous-intensity/high-intensity exercise training augment skeletal muscle carnitine palmitoyltransferase (CPT) enzyme capacity and activity. Human endurance training studies demonstrate increased CPT-1 enzyme activity and enhanced fatty acid transport capacity in skeletal muscle homogenates compared to sedentary controls. Similarly, comparative training studies evaluating high-intensity intermittent training protocols demonstrate significant increases in maximal CPT-I and CPT-II enzyme activities and mitochondrial lipid transport capacity.
At least one human study found that vigorous-intensity aerobic exercise enhances markers of mitophagy.
"There's not a lot of direct human research on the effects of different training types of exercise on mitophagy, but I know of at least one human study that has found particularly vigorous-intensity aerobic exercise enhances markers of mitophagy." (said at 0:33:19)
Human research on mitophagy responses to exercise is limited, but published clinical trials have evaluated markers of mitophagy in human skeletal muscle following different exercise protocols. A clinical trial in young male subjects compared 8 weeks of continuous moderate-intensity cycling with high-intensity sprint-interspersed cycling (a form of vigorous aerobic training). The study found that 8 weeks of exercise training significantly increased skeletal muscle protein content of Parkin and BNIP3—key regulatory markers of mitophagy—with no significant difference in the magnitude of adaptation between moderate continuous exercise and sprint-interspersed exercise (PMID: 29626392). Earlier acute studies (e.g., PMID: 28272266) had found mixed or delayed responses of mitophagy markers after acute endurance cycling in humans, confirming the speaker's qualification that direct human evidence is sparse but supports an increase in mitophagy markers following vigorous training.
Lactate crosses the blood-brain barrier via MCT transporters to enter the brain.
"And when you produce lactate, it's getting into circulation and it can cross the blood-brain barrier. There are lactate transporters, MCT transporters, on the blood-brain barrier, and it can cross the blood-brain barrier and get into the brain" (said at 0:35:52)
Circulating lactate crosses the blood-brain barrier into the central nervous system via monocarboxylate transporters (MCTs), primarily MCT1 expressed on brain capillary endothelial cells. This is a well-established physiological transport mechanism enabling lactate and other monocarboxylates (such as pyruvate and ketone bodies) to serve as energy substrates and signaling molecules in the brain.
Infusing traumatic brain injury (TBI) patients with sodium lactate improves TBI outcomes as measured by Glasgow scores.
"And there's been a few studies showing that an infusion—patients with TBI that get infused with sodium lactate, this actually improves TBI outcomes, and this is measured by the Glasgow scores." (said at 0:38:54)
Clinical studies have evaluated sodium lactate infusions in patients with traumatic brain injury (TBI) and reported improvements in outcomes assessed by the Glasgow Outcome Scale (GOS). In a randomized controlled trial of 34 patients with severe TBI, hypertonic sodium lactate reduced intracranial pressure more effectively than mannitol and resulted in significantly better long-term neurological recovery on the GOS (PMID: 18807008). Subsequent systematic reviews confirm that while sodium lactate reliably lowers intracranial pressure and serves as a cerebral metabolic substrate, evidence directly demonstrating improved long-term functional recovery remains preliminary and derived from small cohorts.
Animal studies show that lactate stimulates mitochondrial biogenesis in neurons and the brain.
"Lactate again also stimulates mitochondrial biogenesis; animal studies have shown this in the brain and neurons as well." (said at 0:39:26)
Animal studies support the claim that lactate promotes mitochondrial biogenesis in the brain and neurons. In rodent models, systemic or local lactate administration has been shown to induce key markers of mitochondrial biogenesis—such as PGC-1α mRNA expression and mitochondrial DNA copy number—in brain regions including the hippocampus and anterior cingulate cortex via monocarboxylate transporters (MCTs). Because this evidence is derived exclusively from preclinical rodent experiments and in vitro/mechanistic models, the certainty of evidence remains very low.
Lactate signaling in the brain increases brain-derived neurotrophic factor (BDNF).
"It also signals to the brain to make more brain-derived neurotrophic factor (BDNF)." (said at 0:41:00)
Preclinical and translational research demonstrates that lactate functions as a signaling molecule in the central nervous system. In rodent models of exercise, muscle-derived lactate crosses the blood-brain barrier via monocarboxylate transporters and induces hippocampal brain-derived neurotrophic factor (BDNF) expression and TrkB signaling through a SIRT1-dependent pathway involving PGC-1α and FNDC5. Human studies also show that exogenous lactate infusion increases circulating BDNF isoforms.
Lactate signals to increase vascular endothelial growth factor (VEGF) at the blood-brain barrier to promote angiogenesis and repair blood vessels.
"So lactate signals to increase another growth factor at the blood-brain barrier called VEGF, and this is vascular endothelial growth factor. This helps grow new tiny blood vessels; this is called angiogenesis, the growth of new tiny blood vessels. It helps them grow at the blood-brain barrier. It also helps repair damaged blood vessels." (said at 0:42:02)
Preclinical evidence supports the claim that lactate signaling increases vascular endothelial growth factor A (VEGFA) and promotes cerebral angiogenesis. In mouse models, elevated blood lactate levels (via exercise or lactate injection) activate the hydroxycarboxylic acid receptor 1 (HCAR1) on perivascular cells along cerebral microvessels, leading to increased brain VEGFA expression and enhanced capillary density. Because the evidence for this specific mechanism is derived from animal models, the overall level of certainty is very low.
Breakdown of the blood-brain barrier is emerging as one of the earliest signs of dementia.
"And there's also emerging evidence that now suggests breakdown of the blood-brain barrier is one of the earliest signs of dementia." (said at 0:43:04)
Substantial clinical and neuroimaging evidence indicates that breakdown of the blood-brain barrier (BBB) occurs early in the course of cognitive impairment and dementia, including Alzheimer's disease. Prospective biomarker and dynamic contrast-enhanced MRI studies demonstrate BBB breakdown and pericyte injury (such as elevated CSF soluble PDGFRβ) in the hippocampus and medial temporal lobe in individuals with early cognitive dysfunction and cognitively unimpaired individuals carrying the APOE4 allele, predicting subsequent cognitive decline independently of classical amyloid-β and tau pathology.
Interleukin-6 (IL-6) produced by muscle during exercise stimulates the production of anti-inflammatory cytokines such as IL-10.
"When it is produced from muscle, it acts as a myokine, so it does play a role in inflammation, but when it's produced from muscle during exercise, it's signaling to other tissues to have an anti-inflammatory response. And so you'll often find an even larger production of anti-inflammatory cytokines, such as IL-10, in response to IL-6 produced during exercise." (said at 0:45:37)
Muscle-derived interleukin-6 (IL-6) released during exercise acts as a myokine and stimulates a systemic anti-inflammatory cascade, including the production and elevation of anti-inflammatory cytokines such as interleukin-10 (IL-10) and interleukin-1 receptor antagonist (IL-1ra), while simultaneously inhibiting pro-inflammatory cytokines such as TNF-alpha. Human physiological trials using recombinant IL-6 infusions mimicking exercise levels directly confirmed that IL-6 induces circulating IL-10 and IL-1ra.
Women who were more physically active prior to a breast cancer diagnosis had approximately a 23% reduced risk of all-cause mortality and a 23% reduced risk of breast cancer mortality.
"So a study investigating physical activity in breast cancer and colorectal cancer found women who were more physically active before being diagnosed with breast cancer had about a 23% reduced risk of dying from any cause and a 23% reduced risk of dying from breast cancer compared to those who were less active." (said at 0:47:13)
The host's statement accurately summarizes the findings from a 2014 systematic review and meta-analysis of observational cohort studies investigating physical activity and mortality in breast and colorectal cancer survivors (PMID: 24644304). The study found that comparing the highest versus lowest levels of pre-diagnosis physical activity among breast cancer survivors, the summary relative risks (RRs) for total (all-cause) mortality and breast cancer-specific mortality were both 0.77 (95% CI: 0.69–0.88 and 0.66–0.90, respectively), which corresponds precisely to a 23% risk reduction for both outcomes.
Individuals who were more active prior to a colorectal cancer diagnosis had a 26% reduced risk of all-cause mortality and approximately a 25% reduced risk of colorectal cancer mortality.
"Those who were more active before being diagnosed with colorectal cancer had a 26% reduced risk of dying from any cause and about a 25% reduced risk of dying from colorectal cancer." (said at 0:47:44)
A systematic review and meta-analysis of prospective cohort studies published in Annals of Oncology examined pre- and post-diagnosis physical activity in colorectal cancer survivors. When comparing the highest versus lowest levels of pre-diagnosis physical activity among colorectal cancer survivors, the summary relative risk was 0.74 (95% CI: 0.63–0.86) for all-cause/total mortality (a 26% risk reduction) and 0.75 (95% CI: 0.62–0.91) for colorectal cancer–specific mortality (a 25% risk reduction), matching the stated statistics.
Being physically active after a cancer diagnosis is associated with a 48% reduced risk of all-cause mortality and 28% reduced risk of breast cancer mortality in breast cancer patients.
"So being active after diagnosis had even stronger benefits for both cancer types: so these women had a 48% reduced risk of dying from any cause and a 28% reduced risk of dying from breast cancer compared to those that were less active after diagnosis" (said at 0:47:44)
The speaker's numbers match the findings of a large systematic review and meta-analysis of prospective cohort studies by Schmid and Leitzmann (2014, PMID 24644304). Evaluating post-diagnosis physical activity in breast cancer survivors, comparing the highest to the lowest levels of activity was associated with a 48% reduced risk of all-cause (total) mortality (summary relative risk [RR] = 0.52, 95% CI: 0.42–0.64) and a 28% reduced risk of breast cancer–specific mortality (summary RR = 0.72, 95% CI: 0.60–0.85). Because these findings are derived from observational cohort studies rather than randomized controlled trials, the GRADE certainty of evidence is low due to the potential for residual confounding and reverse causation.
Being physically active after a colorectal cancer diagnosis is associated with a 42% reduced risk of all-cause mortality and a 39% reduced risk of colorectal cancer mortality.
"and the individuals with colorectal cancer had a 42% reduced risk of dying from any cause and a 39% reduced risk of dying from colorectal cancer, again, after being diagnosed with the cancer." (said at 0:47:44)
The cited figures correspond exactly to findings from a systematic review and meta-analysis of prospective observational studies by Schmid and Leitzmann (2014). Comparing the highest versus lowest categories of physical activity performed after colorectal cancer diagnosis, the summary relative risk was 0.58 (95% CI: 0.48–0.70) for all-cause (total) mortality (representing a 42% reduction) and 0.61 (95% CI: 0.40–0.92) for colorectal cancer-specific mortality (representing a 39% reduction). Because these findings are derived from observational cohort studies rather than randomized controlled trials, residual confounding and reverse causation cannot be completely excluded, resulting in a low GRADE certainty.
Exercise increases the muscle enzyme kynurenine aminotransferase, which converts kynurenine into kynurenic acid and prevents its accumulation as neurotoxic quinolinic acid.
"So skeletal muscle has the ability to take up a compound known as kynurenine and convert it into kynurenic acid. which is a non-toxic metabolite, um, and it does this by increasing an enzyme on the muscle called kynurenine aminotransferase. So this essentially reduces the amount of kynurenine available to then be transformed into other harmful metabolites, such as quinolinic acid in the brain." (said at 0:49:48)
Exercise training stimulates skeletal muscle expression of kynurenine aminotransferases (KATs) through the PGC-1α1 pathway. KAT converts kynurenine into kynurenic acid, a metabolite that cannot cross the blood-brain barrier. By clearing circulating kynurenine in peripheral muscle tissue, exercise prevents kynurenine from entering the brain, where it would otherwise be metabolized along the neurotoxic branch of the pathway into compounds such as quinolinic acid. This mechanism was demonstrated in preclinical mouse models and confirmed in human endurance exercise trials showing elevated muscle KAT gene and protein expression alongside increased plasma kynurenic acid.
Performing short bouts of exercise snacks immediately before or after meals improves blood glucose control and promotes rapid glucose uptake via GLUT4 transporters.
"Performing these these, you know, short bursts of exercise before or so directly before or after a meal is particularly effective in controlling blood sugar levels, and, you know, this this sort sort of thing can lead to a rapid uptake of glucose into the muscles, again having to do with increasing those GLUT4 transporters." (said at 0:51:23)
Randomized crossover trials and meta-analyses show that performing brief bouts of vigorous exercise ('exercise snacks') around meals reduces postprandial glucose excursions and improves glycaemic control in populations with insulin resistance or type 2 diabetes. Mechanistically, muscle contraction stimulates rapid glucose uptake by promoting the translocation of GLUT4 glucose transporters to the plasma membrane through insulin-independent signaling pathways.
- supports: 'Exercise snacks' before meals: a novel strategy to improve glycaemic control in individua… (Diabetologia 2014) · cited 201x in the literature
"Dosing exercise as brief, intense 'exercise snacks' before main meals is a time-efficient and effective approach to improve glycaemic control in individuals with insulin resistance." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Canonical and Alternative Pathways (Insulin and Exercise) of GLUT4 Synthesis, Signaling, I… (International journal of molecular sciences 2026) · cited 2x in the literature
"Crucially, robust alternative signaling networks function completely independently of insulin to regulate GLUT4 synthesis and translocation. Prominent among these are contraction-mediated pathways in skeletal muscle, which employ calcium signaling (via CaMKII), mechanical/metabolic stress sensors (via p38 MAPK γ/δ), and AMP-activated protein kinase (AMPK)." (abstract, passage verified)
pubmedfull study (doi) - supports: Acute effects of "exercise snacks" on postprandial glucose and insulin responses in popula… (Frontiers in endocrinology 2026)
"In the primary analysis limited to studies reporting postprandial glucose incremental area under the curve (iAUC; k = 5), exercise snacks significantly reduced glucose iAUC (MD = -5.69 mmol·h/L, 95% CI -9.38 to -2.00, P = 0.003)." (abstract, results, passage verified)
pubmedfull study (doi)
At least one study indicates that a 10-minute exercise snack improves cognitive function.
"Methodologies can differ anywhere between 1 minute to 10 minutes, um, but there at least is one study showing that 10 minutes of an exercise snack does improve cognitive function." (said at 0:53:54)
Multiple randomized crossover experimental studies demonstrate that a single 10-minute bout of exercise (whether light-intensity continuous cycling or slow running, or intermittent high-intensity cycling) improves cognitive performance, specifically executive function measured by the Stroop task, along with increased prefrontal cortex activation.
- supports: Positive effect of acute mild exercise on executive function via arousal-related prefronta… (NeuroImage 2014) · cited 442x in the literature
"Twenty-five young individuals performed a color-word matching Stroop task (CWST) and a two-dimensional scale to measure changes of psychological mood states both before and after a 10-minute exercise session on a cycle ergometer at light intensity (30% v(·)o2peak) and, for the control session, without exercise... The acute bout of mild exercise led to improved Stroop performance, which was positively correlated with increased arousal levels." (abstract, results, passage verified)
pubmedfull study (doi) - supports: A transferable high-intensity intermittent exercise improves executive performance in asso… (NeuroImage 2018) · cited 191x in the literature
"Participants performed a CWST before and after the 10-minute exercise session, during both of which cortical hemodynamic changes in the prefrontal cortex were monitored using fNIRS. Acute HIE led to improved Stroop performance reflected by a shortening of the response time related to Stroop interference." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Slow running benefits: Boosts in mood and facilitation of prefrontal cortex function even … (Imaging neuroscience (Cambridge, Mass.) 2026)
"Twenty-four healthy participants completed a 10-minute very slow running session on a treadmill at 35% V̇ o 2peak and a resting control session in randomized order... The results show that 10 minutes of very slow running significantly enhanced mood, reduced Stroop interference time (i.e., enhanced executive function), and elicited left lateral PFC activation." (abstract, methods and results)
pubmedfull study (doi)
Engaging in 3 to 4 minutes per day of vigorous intermittent lifestyle physical activity (VILPA) is associated with a 25% to 30% reduction in all-cause mortality risk.
"And, um, you know, just 3 to 4 minutes a day of this vigorous intermittent lifestyle physical activity has been shown to be associated with a 25 to 30% reduction in overall mortality risk." (said at 0:54:54)
A prospective cohort study of 25,241 non-exercisers from the UK Biobank (mean follow-up 6.9 years) using wearable accelerometers found that brief bursts of vigorous intermittent lifestyle physical activity (VILPA) were inversely associated with mortality. Specifically, a median VILPA duration of 4.4 minutes per day was associated with a 26% to 30% reduction in all-cause and cancer mortality risk compared to no VILPA. Because this evidence is observational, it shows association rather than definitive causation.
Engaging in approximately 9 minutes per day of VILPA is associated with a 50% reduction in cardiovascular mortality and a 40% reduction in cancer mortality, including among non-exercisers.
"When that VILPA duration is increased to about 9 minutes a day, it's associated with a 50% reduction in cardiovascular-related mortality and a 40% reduction in cancer-related mortality. And these benefits extend even to individuals who identify themselves as non-exercisers." (said at 0:55:26)
The claim is supported by a landmark 2022 UK Biobank accelerometry study (Stamatakis et al.) that tracked 25,241 self-reported non-exercisers over an average follow-up of 6.9 years. The study found that engaging in brief bursts of vigorous intermittent lifestyle physical activity (VILPA) was associated with substantial reductions in mortality compared to no VILPA. Specifically, 3 bouts per day (lasting 1 to 2 minutes each, totaling up to ~9 minutes/day on the higher end of daily VILPA duration) was associated with a 48%–49% reduction in cardiovascular disease mortality and a 38%–40% reduction in cancer mortality among non-exercisers. Because these data come from an observational cohort study, they demonstrate strong inverse associations rather than proven causality, resulting in low certainty.
- supports: Association of wearable device-measured vigorous intermittent lifestyle physical activity … (Nature medicine 2022) · cited 349x in the literature
"Here, we examined the association of VILPA with all-cause, cardiovascular disease (CVD) and cancer mortality in 25,241 nonexercisers (mean age 61.8 years, 14,178 women/11,063 men) in the UK Biobank. Over an average follow-up of 6.9 years, during which 852 deaths occurred, VILPA was inversely associated with all three of these outcomes in a near-linear fashion. Compared with participants who engaged in no VILPA, participants who engaged in VILPA at the sample median VILPA frequency of 3 length-standardized bouts per day (lasting 1 or 2 min each) showed a 38%-40% reduction in all-cause and cancer mortality risk and a 48%-49% reduction in CVD mortality risk." (abstract, results, passage verified)
pubmedfull study (doi)
Neuronal lactate utilization spares glucose to enter the pentose phosphate pathway, which produces NADPH required for glutathione synthesis in the brain.
"It's freeing up glucose to be used by another biochemical pathway known as the pentose phosphate pathway, and this pathway uses glucose to make precursors called NADPH that's needed for the production of one of the most powerful antioxidant systems in the brain, called glutathione." (said at 0:37:53)
The mechanistic model of brain bioenergetics indicates that when neurons utilize lactate as an oxidative energy substrate, glucose can be spared for flux through the pentose phosphate pathway (PPP). The PPP oxidizes glucose-6-phosphate to generate NADPH, which provides the reducing equivalents required by glutathione reductase to maintain the pool of reduced glutathione (GSH), a critical antioxidant defense against reactive oxygen species. While NADPH is specifically required for the regeneration of active reduced glutathione rather than de novo tripeptide synthesis, the described metabolic relationship is well-documented in cellular and animal neuroscience research.
- supports: D-Glucose prevents glutathione oxidation and mitochondrial damage after glutamate receptor… (Journal of neurochemistry 2000) · cited 80x in the literature
"In contrast, D-glucose, but not L-glucose, abolished glutamate-mediated glutathione oxidation and NADPH depletion. Our results suggest that NADPH production from D-glucose accounts for glutathione regeneration and protection from mitochondrial dysfunction. This supports the notion that the activity of the pentose phosphate pathway may be an important factor in protecting neurons against glutamate neurotoxicity." (abstract, results, passage verified)
pubmedfull study (doi) - supports: The bioenergetic and antioxidant status of neurons is controlled by continuous degradation… (Nature cell biology 2009) · cited 859x in the literature
"This, however, was accompanied by a marked decrease in the oxidation of glucose through the pentose phosphate pathway (a metabolic route involved in the regeneration of reduced glutathione) resulting in oxidative stress and apoptotic death. Thus, by actively downregulating glycolysis by APC/C-Cdh1, neurons use glucose to maintain their antioxidant status at the expense of its utilization for bioenergetic purposes." (abstract, results, passage verified)
pubmedfull study (doi)
Sedentary behavior increases the risk of premature death independently of whether an individual engages in physical activity.
"Sedentary behavior has been shown to be a modest independent risk factor for certain types of cancer, um, and it can also increase the risk of premature death even among physically active individuals." (said at 0:53:24)
Large meta-analyses of prospective cohort studies support that prolonged sedentary time is independently associated with an increased risk of cancer incidence, cancer mortality, and all-cause premature mortality after adjusting for physical activity. While very high levels of moderate-to-vigorous physical activity (~60–75 minutes per day) can eliminate the mortality risk associated with total daily sitting time, elevated risks remain present across typical activity levels, and prolonged television viewing remains associated with higher mortality even among highly active individuals.
- supports: Sedentary time and its association with risk for disease incidence, mortality, and hospita… (Annals of internal medicine 2015) · cited 2719x in the literature
"Significant hazard ratio (HR) associations were found with all-cause mortality (HR, 1.240 [95% CI, 1.090 to 1.410]), cardiovascular disease mortality (HR, 1.179 [CI, 1.106 to 1.257]), cardiovascular disease incidence (HR, 1.143 [CI, 1.002 to 1.729]), cancer mortality (HR, 1.173 [CI, 1.108 to 1.242]), cancer incidence (HR, 1.130 [CI, 1.053 to 1.213]), and type 2 diabetes incidence (HR, 1.910 [CI, 1.642 to 2.222]). Hazard ratios associated with sedentary time and outcomes were generally more pronounced at lower levels of physical activity than at higher levels." (abstract, results, passage verified)
pubmedfull study (doi) - context: Does physical activity attenuate, or even eliminate, the detrimental association of sittin… (Lancet (London, England) 2016) · cited 2724x in the literature
"High levels of moderate intensity physical activity (ie, about 60-75 min per day) seem to eliminate the increased risk of death associated with high sitting time. However, this high activity level attenuates, but does not eliminate the increased risk associated with high TV-viewing time." (abstract, conclusions, passage verified)
pubmedfull study (doi)
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.